You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PD-L1 PET

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • 89Zr-atezolizumab PET/CT
  • (no location specified)
Feb 22, 2023

NSCLC Stage IV Trial in Netherlands (18F-PD-L1)

Recruiting
  • NSCLC Stage IV
  • 18F-PD-L1
  • Amersfoort, Netherlands
  • +7 more
Nov 7, 2022

Large B-cell Lymphoma Trial in Groningen (89Zr-atezolizumab PET-imaging)

Recruiting
  • Large B-cell Lymphoma
  • 89Zr-atezolizumab PET-imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 15, 2022

Solid Tumor, Positron-Emission Tomography(PET) Trial in Suzhou ([68Ga]Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • [68Ga]Ga-NOTA-SNA002
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 3, 2022

Rectal Cancer Stage, Oesophageal Cancer Trial in Vienna (CRT, SCPRT, CROSS Protocol)

Not yet recruiting
  • Rectal Cancer Stage
  • Oesophageal Cancer
  • CRT
  • +3 more
  • Vienna, Austria
    Medical University of Vienna
Mar 26, 2022

Cancer Head Neck, Metastatic Cancer, Metastatic Lung Cancer Trial in New Haven (adnectin 18F-BMS-986192 Head and Neck Cancer,

Not yet recruiting
  • Cancer Head Neck
  • +2 more
  • adnectin 18F-BMS-986192 Head and Neck Cancer
  • adnectin 18F-BMS-986192 Brain Metastases
  • New Haven, Connecticut
    Yale University PET Center
Oct 10, 2022

Radiomics for prEdiction of lunG cAncer biologY

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • PET/CT
  • Poitiers, France
    CHU Poitiers
Apr 5, 2023

Solid Tumor, Lung Cancer Trial in Beijing (18F-WL12 PET or 68Ga-WL12 PET)

Recruiting
  • Solid Tumor
  • Lung Cancer
  • 18F-WL12 PET or 68Ga-WL12 PET
  • Beijing, China
    Shunlian Zhou
Jul 18, 2022

Gastrointestinal Tumors Trial in Beijing (68Ga-WL12 PET/CT)

Recruiting
  • Gastrointestinal Tumors
  • 68Ga-WL12 PET/CT
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jul 18, 2022

Melanoma Trial in Groningen (PD-L1 PET imaging)

Completed
  • Melanoma
  • PD-L1 PET imaging
  • Groningen, Netherlands
    UMCG
Apr 26, 2021

Lung Cancer, Melanoma, PD-L1 Trial in Beijing (68Ga-THP-APN09)

Recruiting
  • Lung Cancer
  • +3 more
  • 68Ga-THP-APN09
  • Beijing, Beijing, China
    Beijing cancer hospital
Dec 12, 2021

Head Neck Cancer Trial in Netherlands (PD-L1 imaging, Durvalumab)

Completed
  • Head and Neck Cancer
  • Amsterdam, Netherlands
  • +3 more
Jan 6, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
May 1, 2023

Non Small Cell Lung Cancer Trial in Nijmegen (89Zr-avelumab PET, Avelumab)

Completed
  • Non Small Cell Lung Cancer
  • Nijmegen, Netherlands
    Radboud University
Jan 6, 2022

Oral Cavity Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab)

Active, not recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Amsterdam, Noord-Holland, Netherlands
    VU University medical center
Oct 6, 2021

Solid Tumor, Adult Trial in Wuxi (89Zr-KN035)

Recruiting
  • Solid Tumor, Adult
  • Wuxi, Jiangsu, China
    Wuxi No. 4 People's Hospital
Jul 20, 2021

NSCLC (NSCLC) Trial in Baltimore ([18F]F-AraG Injection)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • [18F]F-AraG Injection
  • Baltimore, Maryland
    Johns Hopkins University
Dec 14, 2021

Advanced Solid Tumor Trial in Amsterdam, Groningen (89Zr-S095012 tracer and S095012 will be administered via an IV infusion)

Recruiting
  • Advanced Solid Tumor
  • 89Zr-S095012 tracer and S095012 will be administered via an IV infusion
  • Amsterdam, Netherlands
  • +1 more
Dec 9, 2022

Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression Trial in Groningen (89Zr-MPDL-3280A-PET scans)

Active, not recruiting
  • Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression
  • 89Zr-MPDL-3280A-PET scans
  • Groningen, Netherlands
    University Medical Center Groningen
Feb 28, 2022

Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)

Not yet recruiting
  • Advanced Non Small Cell Lung Cancer
  • (no location specified)
Oct 24, 2023

Lung Cancer, Colorectal Cancer Trial in Beijing (18F-FDG)

Recruiting
  • Lung Cancer
  • Colorectal Cancer
  • Beijing, China
    Beijing Cancer Hospital
Mar 27, 2023

Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell

Not yet recruiting
  • Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +5 more
  • (no location specified)
Jul 13, 2023

Lung Cancer Trial (Centipeda minima+PD-1/PD-L1 inhibitor, PD-1/PD-L1 inhibitor)

Not yet recruiting
  • Lung Cancer
  • Centipeda minima+PD-1/PD-L1 inhibitor
  • PD-1/PD-L1 inhibitor
  • (no location specified)
Feb 17, 2023

Advanced Solid Tumor Trial in Beijing (Inosine 0.2g orally 3 times/day, PD-1/PD-L1 inhibitor ,chemo/targeting)

Completed
  • Advanced Solid Tumor
  • Inosine 0.2g orally 3 times/day
  • PD-1/PD-L1 inhibitor ,chemotherapy/targeting
  • Beijing, Beijing, China
    Qin li
Mar 30, 2023

Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

Recruiting
  • Digestive System Cancers
  • Beijing, China
    Peking University Cancer Hospital
Oct 25, 2023